CORRECTING AND REPLACING -- MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference
January 05 2017 - 10:27AM
In a release issued under the same headline earlier today by
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD), please note
that in the first paragraph the date of the presentation should
be Thursday, January 12, 2017, not today as previously stated.
The corrected release follows:
MannKind Corporation to Present at the J.P. Morgan 2017
Healthcare Conference
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD), focused on the
discovery and development of therapeutic products for diabetes,
will present on Thursday, January 12, 2017 at the 35th Annual J.P.
Morgan Healthcare Conference at 10:00 AM (PST) at the Westin St.
Francis Hotel in San Francisco, California.
Presenting from the Company will be its Chief Executive Officer,
Matthew J. Pfeffer.
Interested parties can access a link to the live webcast of the
presentations from the News & Events section of the Company's
website at http://www.mannkindcorp.com.
About MannKind CorporationMannKind Corporation
(Nasdaq:MNKD) (TASE:MNKD) focuses on the discovery and development
of therapeutic products for patients with diseases such as
diabetes. MannKind maintains a website at
http://www.mannkindcorp.com to which MannKind regularly posts
copies of its press releases as well as additional information
about MannKind. Interested persons can subscribe on the MannKind
website to e-mail alerts that are sent automatically when MannKind
issues press releases, files its reports with the Securities and
Exchange Commission or posts certain other information to the
website.
Company Contact:
Rose Alinaya
SVP Finance
661-775-5300
ralinaya@mannkindcorp.com
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Sep 2024 to Oct 2024
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Oct 2023 to Oct 2024